Table 5.
Patient characteristics on admission by prognostic outcome
| Item |
Survivors (n = 13) |
Non-survivors (n = 8) |
p |
| Age |
69.4 (8.9) |
74.9 (9.3) |
0.193 |
| BMI (kg/m2) |
22.3 (3.5) |
22.5 (1.7) |
0.872 |
| β-DG (pg/ml) |
93.8 (161) |
82 (64.2) |
0.846 |
| KL-6 (U/ml) |
771 (461) |
1588 (1417) |
0.104 |
| LDH (IU/l) |
521 (276) |
799 (329) |
0.051 |
| CRP (mg/dl) |
8.22 (4.35) |
9.62 (4.92) |
0.502 |
| Alb/BUN |
0.211 (0.133) |
0.119 (0.054) |
0.078 |
| Lymphocytes (/μl) |
1203 (1011) |
752 (389) |
0.28 |
| Neutrophils (/μl) |
7181 (3012) |
7511 (3083) |
0.825 |
| WBC (/μl) |
9323 (3581) |
8700 (3103) |
0.7 |
| Interval from admission to PCP diagnosis (days) |
|
||
| |
4 (2.83) |
7.88 (3.56) |
0.012 |
| Interval from admission to start PCP-specific treatment (days) |
|
||
| 1.77 (2.74) | 6.88 (4.67) | 0.005 | |